| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystrophin | 109 | 2023 | 284 | 10.060 |
Why?
|
| Muscular Dystrophies | 109 | 2023 | 389 | 9.490 |
Why?
|
| Muscular Dystrophy, Duchenne | 25 | 2022 | 268 | 5.260 |
Why?
|
| Muscular Dystrophy, Animal | 30 | 2020 | 88 | 4.220 |
Why?
|
| Zebrafish | 36 | 2023 | 2997 | 3.420 |
Why?
|
| Muscle, Skeletal | 77 | 2024 | 4924 | 3.300 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 11 | 2020 | 48 | 2.830 |
Why?
|
| Muscle Proteins | 49 | 2019 | 1152 | 2.480 |
Why?
|
| Zebrafish Proteins | 13 | 2019 | 1006 | 2.000 |
Why?
|
| Myoblasts | 13 | 2021 | 232 | 1.850 |
Why?
|
| Dystrophin-Associated Proteins | 14 | 2023 | 59 | 1.660 |
Why?
|
| Cytoskeletal Proteins | 30 | 2004 | 1344 | 1.570 |
Why?
|
| Muscle Development | 12 | 2021 | 259 | 1.540 |
Why?
|
| Muscles | 39 | 2013 | 1581 | 1.320 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2020 | 88 | 1.240 |
Why?
|
| Intermediate Filament Proteins | 6 | 2009 | 263 | 1.210 |
Why?
|
| Muscle Fibers, Skeletal | 13 | 2017 | 542 | 1.190 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 9 | 2018 | 62 | 1.130 |
Why?
|
| Drug Evaluation, Preclinical | 6 | 2020 | 1347 | 0.990 |
Why?
|
| Cloning, Molecular | 40 | 2011 | 4169 | 0.980 |
Why?
|
| Muscle Cells | 6 | 2017 | 195 | 0.890 |
Why?
|
| Genetic Linkage | 29 | 2013 | 2381 | 0.860 |
Why?
|
| Stem Cells | 9 | 2012 | 3524 | 0.860 |
Why?
|
| Exons | 32 | 2022 | 2389 | 0.850 |
Why?
|
| Mice, Inbred mdx | 15 | 2019 | 88 | 0.840 |
Why?
|
| Muscular Diseases | 10 | 2024 | 551 | 0.830 |
Why?
|
| Membrane Proteins | 25 | 2019 | 7850 | 0.820 |
Why?
|
| Chromosome Mapping | 56 | 2014 | 4626 | 0.820 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2020 | 199 | 0.800 |
Why?
|
| X Chromosome | 32 | 1999 | 815 | 0.790 |
Why?
|
| Swimming | 2 | 2023 | 207 | 0.770 |
Why?
|
| MicroRNAs | 6 | 2014 | 3787 | 0.760 |
Why?
|
| Gene Expression | 19 | 2019 | 7587 | 0.750 |
Why?
|
| Membrane Glycoproteins | 20 | 2004 | 3709 | 0.740 |
Why?
|
| Animals | 141 | 2023 | 167960 | 0.740 |
Why?
|
| Disease Models, Animal | 26 | 2019 | 18137 | 0.740 |
Why?
|
| Sarcoglycans | 18 | 2016 | 57 | 0.720 |
Why?
|
| Neuropeptides | 7 | 2023 | 943 | 0.680 |
Why?
|
| Molecular Sequence Data | 59 | 2014 | 17624 | 0.670 |
Why?
|
| Chromosome Deletion | 25 | 1992 | 1387 | 0.640 |
Why?
|
| Base Sequence | 53 | 2016 | 12444 | 0.610 |
Why?
|
| Autistic Disorder | 3 | 2013 | 1214 | 0.600 |
Why?
|
| Mutation | 43 | 2021 | 29957 | 0.590 |
Why?
|
| Dystroglycans | 12 | 2023 | 62 | 0.580 |
Why?
|
| Gene Expression Regulation | 15 | 2012 | 11902 | 0.560 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 2448 | 0.560 |
Why?
|
| Actinin | 9 | 2012 | 163 | 0.560 |
Why?
|
| Contractile Proteins | 5 | 2006 | 240 | 0.560 |
Why?
|
| Amino Acid Sequence | 42 | 2014 | 13451 | 0.550 |
Why?
|
| Cell Differentiation | 15 | 2014 | 11481 | 0.540 |
Why?
|
| DNA Mutational Analysis | 16 | 2013 | 4108 | 0.540 |
Why?
|
| Cell Transplantation | 4 | 2006 | 472 | 0.530 |
Why?
|
| DNA, Complementary | 20 | 2011 | 1991 | 0.510 |
Why?
|
| Serotonin | 1 | 2020 | 1040 | 0.510 |
Why?
|
| Quinolines | 1 | 2020 | 759 | 0.500 |
Why?
|
| Microfilament Proteins | 6 | 2006 | 1135 | 0.500 |
Why?
|
| Phenotype | 37 | 2024 | 16548 | 0.480 |
Why?
|
| Glycosyltransferases | 2 | 2018 | 118 | 0.480 |
Why?
|
| Mice | 74 | 2023 | 81209 | 0.470 |
Why?
|
| RNA, Messenger | 27 | 2021 | 12762 | 0.470 |
Why?
|
| Longevity | 8 | 2010 | 1050 | 0.460 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2013 | 32 | 0.460 |
Why?
|
| Transcription, Genetic | 18 | 2021 | 7593 | 0.450 |
Why?
|
| Alternative Splicing | 11 | 2023 | 1091 | 0.450 |
Why?
|
| Gene Expression Profiling | 17 | 2019 | 9406 | 0.450 |
Why?
|
| Cell Separation | 8 | 2016 | 1720 | 0.450 |
Why?
|
| Granulomatous Disease, Chronic | 4 | 2010 | 173 | 0.430 |
Why?
|
| Calcium-Binding Proteins | 4 | 2015 | 1067 | 0.420 |
Why?
|
| Nerve Tissue Proteins | 8 | 2014 | 4408 | 0.420 |
Why?
|
| Homeodomain Proteins | 4 | 2020 | 2414 | 0.420 |
Why?
|
| Side-Population Cells | 1 | 2012 | 12 | 0.420 |
Why?
|
| Muscular Atrophy, Spinal | 7 | 2000 | 258 | 0.420 |
Why?
|
| Bone Marrow Cells | 5 | 2008 | 2414 | 0.410 |
Why?
|
| Satellite Cells, Skeletal Muscle | 6 | 2016 | 126 | 0.410 |
Why?
|
| Integrin beta4 | 1 | 2012 | 31 | 0.400 |
Why?
|
| Drug Discovery | 2 | 2023 | 1057 | 0.400 |
Why?
|
| Pedigree | 30 | 2021 | 4578 | 0.390 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 364 | 0.380 |
Why?
|
| RNA Editing | 1 | 2012 | 151 | 0.370 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 6 | 2000 | 783 | 0.370 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2013 | 557 | 0.370 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2014 | 3774 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 23 | 2015 | 22020 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 5 | 7 | 2009 | 385 | 0.360 |
Why?
|
| Polymerase Chain Reaction | 20 | 2012 | 6065 | 0.360 |
Why?
|
| Genes | 18 | 2013 | 1845 | 0.350 |
Why?
|
| Dogs | 8 | 2022 | 3841 | 0.350 |
Why?
|
| Humans | 241 | 2024 | 760613 | 0.350 |
Why?
|
| Pyrazoles | 1 | 2020 | 1999 | 0.350 |
Why?
|
| Cells, Cultured | 19 | 2019 | 18955 | 0.340 |
Why?
|
| Sarcomeres | 4 | 2016 | 367 | 0.340 |
Why?
|
| DNA | 36 | 2001 | 7233 | 0.340 |
Why?
|
| RNA Splice Sites | 3 | 2019 | 211 | 0.330 |
Why?
|
| Proteins | 5 | 2018 | 6029 | 0.330 |
Why?
|
| Sequence Homology, Amino Acid | 13 | 2003 | 2753 | 0.320 |
Why?
|
| Animals, Genetically Modified | 6 | 2019 | 1553 | 0.310 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1115 | 0.310 |
Why?
|
| Protein Isoforms | 6 | 2012 | 1697 | 0.300 |
Why?
|
| RNA Splicing | 3 | 2008 | 915 | 0.300 |
Why?
|
| Carrier Proteins | 5 | 2014 | 4938 | 0.300 |
Why?
|
| Immunohistochemistry | 28 | 2012 | 11070 | 0.290 |
Why?
|
| Utrophin | 9 | 2015 | 17 | 0.290 |
Why?
|
| Laminin | 5 | 2012 | 405 | 0.290 |
Why?
|
| Fish Diseases | 1 | 2007 | 37 | 0.290 |
Why?
|
| Genetic Markers | 16 | 2014 | 2609 | 0.290 |
Why?
|
| Genetic Privacy | 1 | 2007 | 60 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2001 | 363 | 0.280 |
Why?
|
| Mitochondria, Muscle | 2 | 2018 | 172 | 0.270 |
Why?
|
| Green Fluorescent Proteins | 6 | 2012 | 2057 | 0.270 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 374 | 0.270 |
Why?
|
| Genetic Research | 1 | 2007 | 172 | 0.270 |
Why?
|
| Patient Access to Records | 1 | 2007 | 119 | 0.260 |
Why?
|
| Software | 3 | 2018 | 4419 | 0.260 |
Why?
|
| Homozygote | 6 | 2016 | 1788 | 0.260 |
Why?
|
| Blotting, Western | 14 | 2012 | 5039 | 0.260 |
Why?
|
| Desmin | 2 | 2006 | 99 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2019 | 3604 | 0.250 |
Why?
|
| Cerebellum | 1 | 2012 | 1495 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 20 | 3 | 2000 | 127 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4571 | 0.240 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 728 | 0.240 |
Why?
|
| Genome, Human | 4 | 2010 | 4418 | 0.240 |
Why?
|
| Aging | 7 | 2011 | 8652 | 0.240 |
Why?
|
| DNA Primers | 10 | 2012 | 2818 | 0.240 |
Why?
|
| Stem Cell Transplantation | 3 | 2009 | 1601 | 0.230 |
Why?
|
| Sequence Homology, Nucleic Acid | 7 | 2014 | 1055 | 0.230 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2013 | 0.230 |
Why?
|
| Bone Marrow Transplantation | 4 | 2008 | 2693 | 0.230 |
Why?
|
| Heterozygote | 8 | 2011 | 2798 | 0.230 |
Why?
|
| Spinal Cord | 2 | 2009 | 1817 | 0.230 |
Why?
|
| Myoblasts, Skeletal | 1 | 2004 | 75 | 0.220 |
Why?
|
| Family Health | 3 | 2013 | 1257 | 0.220 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2013 | 599 | 0.220 |
Why?
|
| Multigene Family | 5 | 2002 | 1077 | 0.220 |
Why?
|
| Male | 107 | 2024 | 359718 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 1995 | 635 | 0.220 |
Why?
|
| Calpain | 4 | 2007 | 145 | 0.210 |
Why?
|
| Gene Library | 6 | 2012 | 1060 | 0.210 |
Why?
|
| Genetics, Medical | 2 | 2005 | 336 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 13 | 2004 | 2471 | 0.210 |
Why?
|
| Muscle Contraction | 2 | 2019 | 1201 | 0.210 |
Why?
|
| Immunoblotting | 12 | 2003 | 1649 | 0.210 |
Why?
|
| Larva | 2 | 2023 | 509 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 1091 | 0.210 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2014 | 2505 | 0.210 |
Why?
|
| Models, Biological | 3 | 2018 | 9468 | 0.210 |
Why?
|
| Brain | 15 | 2013 | 26951 | 0.200 |
Why?
|
| Polymorphism, Restriction Fragment Length | 10 | 1992 | 761 | 0.200 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2011 | 611 | 0.200 |
Why?
|
| Pentosyltransferases | 3 | 2018 | 62 | 0.200 |
Why?
|
| Gene Deletion | 6 | 2014 | 2668 | 0.200 |
Why?
|
| Genetic Loci | 2 | 2014 | 2618 | 0.200 |
Why?
|
| Nanopores | 1 | 2022 | 44 | 0.200 |
Why?
|
| Cell Line | 12 | 2021 | 15620 | 0.200 |
Why?
|
| Caveolins | 2 | 2001 | 102 | 0.200 |
Why?
|
| Child | 38 | 2023 | 79799 | 0.190 |
Why?
|
| Polymorphism, Genetic | 14 | 2009 | 4286 | 0.190 |
Why?
|
| Cadherins | 2 | 1997 | 898 | 0.190 |
Why?
|
| Dog Diseases | 3 | 2015 | 141 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 69 | 0.190 |
Why?
|
| Sarcolemma | 4 | 2004 | 65 | 0.180 |
Why?
|
| Introns | 7 | 2022 | 978 | 0.180 |
Why?
|
| Birefringence | 1 | 2020 | 54 | 0.180 |
Why?
|
| Lod Score | 9 | 2010 | 602 | 0.180 |
Why?
|
| Genetic Testing | 5 | 2019 | 3531 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2014 | 4122 | 0.180 |
Why?
|
| Myotonic Dystrophy | 1 | 2021 | 78 | 0.180 |
Why?
|
| Informed Consent | 1 | 2007 | 1005 | 0.180 |
Why?
|
| Awards and Prizes | 1 | 2005 | 359 | 0.180 |
Why?
|
| Brain Chemistry | 4 | 1998 | 959 | 0.180 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2020 | 155 | 0.180 |
Why?
|
| Sequence Alignment | 7 | 2014 | 2176 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2007 | 1612 | 0.170 |
Why?
|
| Cell Lineage | 3 | 2008 | 2532 | 0.170 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 93 | 0.170 |
Why?
|
| Transduction, Genetic | 3 | 2009 | 897 | 0.170 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2020 | 151 | 0.170 |
Why?
|
| Lentivirus | 3 | 2009 | 506 | 0.170 |
Why?
|
| Receptors, Serotonin | 1 | 2020 | 208 | 0.170 |
Why?
|
| Haplotypes | 4 | 2013 | 2764 | 0.170 |
Why?
|
| Ocular Motility Disorders | 1 | 2001 | 143 | 0.170 |
Why?
|
| Myotonia Congenita | 1 | 2019 | 16 | 0.160 |
Why?
|
| Female | 91 | 2024 | 391246 | 0.160 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2018 | 32 | 0.160 |
Why?
|
| Karyopherins | 1 | 2019 | 130 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17790 | 0.160 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 367 | 0.160 |
Why?
|
| Cell Count | 5 | 2012 | 1835 | 0.160 |
Why?
|
| Osteochondrodysplasias | 1 | 2000 | 182 | 0.160 |
Why?
|
| Child, Preschool | 20 | 2015 | 42056 | 0.150 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.150 |
Why?
|
| Insulin | 1 | 2013 | 6596 | 0.150 |
Why?
|
| RNA | 5 | 2005 | 2723 | 0.150 |
Why?
|
| Leucine | 1 | 1999 | 547 | 0.150 |
Why?
|
| Precipitin Tests | 5 | 2001 | 814 | 0.150 |
Why?
|
| Regeneration | 4 | 2012 | 1506 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 435 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2001 | 1544 | 0.150 |
Why?
|
| Mutation, Missense | 4 | 2015 | 2567 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 2 | 1994 | 1078 | 0.150 |
Why?
|
| Organ Specificity | 6 | 2004 | 1954 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 1997 | 246 | 0.150 |
Why?
|
| Chromosome Aberrations | 5 | 1997 | 1767 | 0.140 |
Why?
|
| Hypophosphatemia, Familial | 1 | 1997 | 32 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1652 | 0.140 |
Why?
|
| Tetany | 1 | 2016 | 13 | 0.140 |
Why?
|
| Genes, Dominant | 3 | 2000 | 863 | 0.140 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 568 | 0.140 |
Why?
|
| Cell Fusion | 4 | 2009 | 293 | 0.140 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1664 | 0.140 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2016 | 52 | 0.140 |
Why?
|
| Kangai-1 Protein | 1 | 2016 | 22 | 0.140 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2016 | 70 | 0.140 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2011 | 438 | 0.140 |
Why?
|
| Actins | 2 | 2012 | 2049 | 0.140 |
Why?
|
| Pseudogenes | 2 | 1999 | 103 | 0.140 |
Why?
|
| Synaptic Membranes | 1 | 1996 | 89 | 0.130 |
Why?
|
| Small Molecule Libraries | 2 | 2013 | 734 | 0.130 |
Why?
|
| Codon, Nonsense | 2 | 2016 | 281 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1999 | 410 | 0.130 |
Why?
|
| Adolescent | 29 | 2024 | 87809 | 0.130 |
Why?
|
| Tissue Distribution | 8 | 1999 | 2262 | 0.130 |
Why?
|
| Oculomotor Muscles | 2 | 2001 | 407 | 0.130 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 1997 | 162 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2014 | 15790 | 0.130 |
Why?
|
| Dental Care for Children | 1 | 2015 | 54 | 0.130 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1986 | 168 | 0.130 |
Why?
|
| Cluster Analysis | 4 | 2013 | 2698 | 0.130 |
Why?
|
| Down-Regulation | 4 | 2014 | 2913 | 0.130 |
Why?
|
| Signal Transduction | 7 | 2014 | 23374 | 0.120 |
Why?
|
| Antibodies | 5 | 1997 | 2421 | 0.120 |
Why?
|
| Mice, Mutant Strains | 6 | 2015 | 1754 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 854 | 0.120 |
Why?
|
| DNA Restriction Enzymes | 11 | 1990 | 553 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2001 | 2208 | 0.120 |
Why?
|
| Neuromuscular Diseases | 3 | 1992 | 256 | 0.120 |
Why?
|
| Blotting, Northern | 5 | 1999 | 1543 | 0.120 |
Why?
|
| Receptors, Transferrin | 1 | 2015 | 291 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1996 | 419 | 0.110 |
Why?
|
| Cell Compartmentation | 2 | 2012 | 384 | 0.110 |
Why?
|
| Dynamin III | 1 | 2013 | 5 | 0.110 |
Why?
|
| PAX7 Transcription Factor | 3 | 2012 | 55 | 0.110 |
Why?
|
| Paired Box Transcription Factors | 2 | 2012 | 207 | 0.110 |
Why?
|
| Wnt2 Protein | 1 | 2013 | 28 | 0.110 |
Why?
|
| Dynamin II | 1 | 2013 | 35 | 0.110 |
Why?
|
| Automation | 2 | 2009 | 580 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2019 | 2773 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2010 | 5659 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2019 | 1575 | 0.110 |
Why?
|
| Skin | 3 | 2004 | 4466 | 0.110 |
Why?
|
| Gene Duplication | 2 | 2007 | 314 | 0.110 |
Why?
|
| Embryo, Nonmammalian | 3 | 2013 | 900 | 0.110 |
Why?
|
| Kidney | 3 | 2007 | 7064 | 0.110 |
Why?
|
| Serum Response Factor | 1 | 2013 | 78 | 0.110 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 61 | 0.110 |
Why?
|
| Myopathies, Nemaline | 2 | 2004 | 73 | 0.110 |
Why?
|
| Nuclear Family | 4 | 2002 | 313 | 0.110 |
Why?
|
| Frizzled Receptors | 1 | 2013 | 90 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 2006 | 2440 | 0.110 |
Why?
|
| Hybrid Cells | 7 | 1995 | 422 | 0.110 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2013 | 103 | 0.110 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2012 | 42 | 0.100 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2012 | 30 | 0.100 |
Why?
|
| Peripheral Nerves | 2 | 1993 | 475 | 0.100 |
Why?
|
| Adenosine Deaminase | 2 | 2012 | 251 | 0.100 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.100 |
Why?
|
| Biopsy | 12 | 2019 | 6771 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2013 | 395 | 0.100 |
Why?
|
| Genetic Complementation Test | 1 | 2013 | 555 | 0.100 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 5 | 2004 | 330 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1994 | 452 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 384 | 0.100 |
Why?
|
| Forecasting | 1 | 2001 | 2931 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 68 | 0.100 |
Why?
|
| RNA-Binding Proteins | 6 | 2012 | 1894 | 0.100 |
Why?
|
| Protein Binding | 7 | 2014 | 9335 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 9530 | 0.100 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 557 | 0.100 |
Why?
|
| Ovum | 1 | 2012 | 187 | 0.100 |
Why?
|
| Siblings | 2 | 2013 | 824 | 0.100 |
Why?
|
| Restriction Mapping | 4 | 1997 | 852 | 0.100 |
Why?
|
| Genetic Variation | 6 | 2003 | 6552 | 0.100 |
Why?
|
| Clinical Protocols | 2 | 2000 | 1440 | 0.100 |
Why?
|
| Gene Components | 2 | 2001 | 27 | 0.100 |
Why?
|
| Adult | 45 | 2021 | 220007 | 0.100 |
Why?
|
| Colon | 1 | 2019 | 1788 | 0.100 |
Why?
|
| Collagen | 1 | 2000 | 2636 | 0.100 |
Why?
|
| Expressed Sequence Tags | 3 | 2007 | 250 | 0.100 |
Why?
|
| In Situ Hybridization | 4 | 2012 | 1900 | 0.100 |
Why?
|
| Antigens, CD | 3 | 2016 | 4000 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 372 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2013 | 555 | 0.090 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 128 | 0.090 |
Why?
|
| Molecular Weight | 8 | 1995 | 2186 | 0.090 |
Why?
|
| Models, Genetic | 8 | 2012 | 3442 | 0.090 |
Why?
|
| Sulfones | 1 | 2013 | 447 | 0.090 |
Why?
|
| Genome | 4 | 2007 | 1739 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2003 | 1744 | 0.090 |
Why?
|
| Receptors, AMPA | 1 | 2012 | 323 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 1997 | 5132 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 697 | 0.090 |
Why?
|
| Shoulder | 1 | 2012 | 299 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2009 | 2825 | 0.090 |
Why?
|
| Social Environment | 1 | 2015 | 1022 | 0.090 |
Why?
|
| Genes, Recessive | 7 | 2012 | 626 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10442 | 0.090 |
Why?
|
| Rats | 10 | 2007 | 23709 | 0.090 |
Why?
|
| Activin Receptors, Type II | 1 | 2011 | 124 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 624 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 1647 | 0.090 |
Why?
|
| Purines | 1 | 2013 | 605 | 0.090 |
Why?
|
| DNA Probes | 6 | 1990 | 551 | 0.090 |
Why?
|
| Cardiomyopathies | 4 | 2004 | 1951 | 0.090 |
Why?
|
| Databases, Genetic | 2 | 2007 | 1738 | 0.090 |
Why?
|
| Steroids | 1 | 2015 | 928 | 0.090 |
Why?
|
| Cerebellar Cortex | 1 | 1990 | 107 | 0.090 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 352 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 10 | 1988 | 1304 | 0.090 |
Why?
|
| Myostatin | 1 | 2011 | 127 | 0.090 |
Why?
|
| Legionnaires' Disease | 2 | 2000 | 49 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 4 | 2009 | 377 | 0.080 |
Why?
|
| Myositis, Inclusion Body | 1 | 2011 | 145 | 0.080 |
Why?
|
| Piperazines | 2 | 2013 | 2525 | 0.080 |
Why?
|
| Anterior Horn Cells | 1 | 2009 | 18 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 358 | 0.080 |
Why?
|
| Animals, Newborn | 3 | 2006 | 2671 | 0.080 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2009 | 17 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 718 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1990 | 375 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2011 | 459 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2012 | 484 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 4 | 1996 | 5782 | 0.080 |
Why?
|
| Receptor, Insulin | 1 | 2013 | 836 | 0.080 |
Why?
|
| Point Mutation | 4 | 2011 | 1594 | 0.080 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 155 | 0.080 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 94 | 0.080 |
Why?
|
| Physical Chromosome Mapping | 2 | 2007 | 182 | 0.080 |
Why?
|
| Vidarabine | 1 | 2010 | 336 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 280 | 0.080 |
Why?
|
| Cell Membrane | 6 | 2004 | 3682 | 0.080 |
Why?
|
| Glycosylation | 2 | 2009 | 1096 | 0.080 |
Why?
|
| Neurons | 4 | 2007 | 9424 | 0.080 |
Why?
|
| Kinetics | 1 | 2016 | 6377 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 3612 | 0.080 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1167 | 0.080 |
Why?
|
| Sequence Deletion | 5 | 2001 | 1493 | 0.080 |
Why?
|
| Blotting, Southern | 6 | 2000 | 777 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2117 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3022 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 442 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 321 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2013 | 728 | 0.080 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1988 | 116 | 0.080 |
Why?
|
| Protein Biosynthesis | 4 | 2003 | 2104 | 0.080 |
Why?
|
| Chromosome Disorders | 3 | 1992 | 499 | 0.080 |
Why?
|
| Computational Biology | 2 | 2019 | 3505 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 666 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4263 | 0.070 |
Why?
|
| Apnea | 1 | 2009 | 195 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3601 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1993 | 819 | 0.070 |
Why?
|
| Chromosome Fragility | 1 | 1987 | 16 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2020 | 10185 | 0.070 |
Why?
|
| Electrophoresis | 3 | 2005 | 234 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 1999 | 315 | 0.070 |
Why?
|
| Microsomes | 3 | 2003 | 252 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2019 | 1919 | 0.070 |
Why?
|
| Reference Values | 5 | 2003 | 4925 | 0.070 |
Why?
|
| SMN Complex Proteins | 4 | 2000 | 41 | 0.070 |
Why?
|
| Fetus | 5 | 1997 | 1859 | 0.070 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 575 | 0.070 |
Why?
|
| Torpedo | 3 | 1996 | 170 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2016 | 6359 | 0.070 |
Why?
|
| Recombination, Genetic | 4 | 1994 | 1526 | 0.070 |
Why?
|
| Aged, 80 and over | 12 | 2015 | 58980 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2019 | 2275 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2013 | 5795 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1617 | 0.070 |
Why?
|
| Infant | 13 | 2021 | 36053 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 2005 | 0.070 |
Why?
|
| Injections, Intra-Arterial | 1 | 2006 | 182 | 0.070 |
Why?
|
| Locomotion | 2 | 2019 | 387 | 0.070 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2007 | 100 | 0.070 |
Why?
|
| Dimerization | 2 | 1998 | 891 | 0.070 |
Why?
|
| Protein Conformation | 4 | 1998 | 3970 | 0.070 |
Why?
|
| Oligonucleotide Probes | 3 | 1991 | 418 | 0.070 |
Why?
|
| Species Specificity | 6 | 2006 | 2418 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2017 | 8311 | 0.070 |
Why?
|
| Receptors, Mitogen | 1 | 2005 | 61 | 0.060 |
Why?
|
| DNA, Recombinant | 5 | 1987 | 455 | 0.060 |
Why?
|
| Ethics Committees, Research | 1 | 2007 | 196 | 0.060 |
Why?
|
| Eye | 1 | 2009 | 710 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2005 | 311 | 0.060 |
Why?
|
| Isoenzymes | 3 | 2003 | 1690 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2012 | 1271 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 751 | 0.060 |
Why?
|
| Cell Nucleus | 4 | 2003 | 2907 | 0.060 |
Why?
|
| Genotype | 7 | 2010 | 12957 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3802 | 0.060 |
Why?
|
| Synapses | 2 | 1992 | 1757 | 0.060 |
Why?
|
| Saudi Arabia | 2 | 2018 | 209 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 2010 | 9185 | 0.060 |
Why?
|
| Genes, ras | 1 | 2007 | 654 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 939 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 1613 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2222 | 0.060 |
Why?
|
| COS Cells | 3 | 2004 | 1129 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2000 | 491 | 0.060 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20080 | 0.060 |
Why?
|
| Calcium | 2 | 1995 | 5725 | 0.060 |
Why?
|
| North America | 1 | 2007 | 1284 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 162 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2803 | 0.060 |
Why?
|
| Prenatal Diagnosis | 5 | 2001 | 1264 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2864 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2013 | 2860 | 0.060 |
Why?
|
| Caregivers | 1 | 2015 | 2224 | 0.050 |
Why?
|
| Rabbits | 4 | 2000 | 4773 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2007 | 1849 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 1990 | 5761 | 0.050 |
Why?
|
| Tunisia | 2 | 2003 | 36 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 1959 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2006 | 839 | 0.050 |
Why?
|
| Sarcoma | 1 | 2014 | 1786 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 4716 | 0.050 |
Why?
|
| Recombinant Proteins | 4 | 2004 | 6538 | 0.050 |
Why?
|
| Clinical Enzyme Tests | 2 | 2001 | 114 | 0.050 |
Why?
|
| Sex Factors | 4 | 2015 | 10546 | 0.050 |
Why?
|
| Caveolin 3 | 2 | 2001 | 24 | 0.050 |
Why?
|
| Transfection | 4 | 2004 | 5781 | 0.050 |
Why?
|
| Quinolones | 1 | 2006 | 377 | 0.050 |
Why?
|
| Clozapine | 1 | 2006 | 506 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2014 | 2698 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 4 | 2006 | 2651 | 0.050 |
Why?
|
| Dermis | 1 | 2003 | 202 | 0.050 |
Why?
|
| Lysine | 1 | 2006 | 1001 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4356 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4815 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2003 | 313 | 0.050 |
Why?
|
| Cadaver | 1 | 2005 | 1345 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2254 | 0.050 |
Why?
|
| Survival of Motor Neuron 1 Protein | 2 | 1998 | 64 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 835 | 0.050 |
Why?
|
| Muscle, Smooth | 3 | 1991 | 924 | 0.050 |
Why?
|
| Family | 3 | 2015 | 3189 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 122 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2003 | 474 | 0.050 |
Why?
|
| Myoglobin | 1 | 2001 | 159 | 0.050 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 1191 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2006 | 1167 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2004 | 1433 | 0.050 |
Why?
|
| Blepharoptosis | 2 | 2009 | 143 | 0.050 |
Why?
|
| Creatine Kinase | 2 | 2001 | 691 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2021 | 4089 | 0.040 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 2 | 1986 | 45 | 0.040 |
Why?
|
| Epidermis | 1 | 2003 | 529 | 0.040 |
Why?
|
| Myocardium | 4 | 2001 | 4700 | 0.040 |
Why?
|
| Young Adult | 5 | 2024 | 58748 | 0.040 |
Why?
|
| Gene Amplification | 2 | 1999 | 1085 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2012 | 41337 | 0.040 |
Why?
|
| Brazil | 3 | 2001 | 1212 | 0.040 |
Why?
|
| Reoperation | 1 | 2010 | 4289 | 0.040 |
Why?
|
| Cell Division | 2 | 2004 | 4463 | 0.040 |
Why?
|
| Myositis | 1 | 2002 | 269 | 0.040 |
Why?
|
| Cell Survival | 2 | 2012 | 5797 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1997 | 3734 | 0.040 |
Why?
|
| Alleles | 6 | 2003 | 6900 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1999 | 286 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8055 | 0.040 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1996 | 113 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2009 | 22052 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2004 | 858 | 0.040 |
Why?
|
| Electric Organ | 2 | 1996 | 55 | 0.040 |
Why?
|
| Cytokines | 4 | 2019 | 7344 | 0.040 |
Why?
|
| Walker-Warburg Syndrome | 1 | 2018 | 15 | 0.040 |
Why?
|
| Glycolysis | 1 | 2003 | 828 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1998 | 98 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 2 | 1990 | 207 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 1006 | 0.040 |
Why?
|
| Sudan | 1 | 2018 | 86 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
| Microscopy, Electron | 4 | 1991 | 2558 | 0.040 |
Why?
|
| Cystine | 1 | 1998 | 94 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1996 | 194 | 0.040 |
Why?
|
| Life Expectancy | 2 | 2002 | 1247 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 622 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2003 | 1516 | 0.040 |
Why?
|
| Probability | 2 | 2002 | 2475 | 0.040 |
Why?
|
| Seminoma | 1 | 1999 | 134 | 0.040 |
Why?
|
| Renal Circulation | 1 | 1998 | 291 | 0.040 |
Why?
|
| Twins, Monozygotic | 2 | 1990 | 469 | 0.040 |
Why?
|
| Morbidity | 2 | 2002 | 1765 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5397 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2001 | 899 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2001 | 1629 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2018 | 202 | 0.040 |
Why?
|
| Diseases in Twins | 2 | 1990 | 447 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2003 | 1083 | 0.040 |
Why?
|
| Apoptosis | 2 | 2012 | 9497 | 0.040 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 1997 | 17 | 0.040 |
Why?
|
| Biological Evolution | 2 | 2002 | 1074 | 0.040 |
Why?
|
| Karyotyping | 3 | 1994 | 1172 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2021 | 943 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 317 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2011 | 14374 | 0.040 |
Why?
|
| Transcription Factors, TFII | 1 | 1997 | 62 | 0.040 |
Why?
|
| Aged | 17 | 2015 | 169143 | 0.040 |
Why?
|
| Distal Myopathies | 1 | 2016 | 18 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1398 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3800 | 0.030 |
Why?
|
| Africa, Northern | 1 | 1996 | 86 | 0.030 |
Why?
|
| Cytogenetics | 1 | 1997 | 198 | 0.030 |
Why?
|
| Egypt | 1 | 2016 | 98 | 0.030 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2016 | 43 | 0.030 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2000 | 240 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 796 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1997 | 333 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 95 | 0.030 |
Why?
|
| Cartilage | 1 | 2000 | 806 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3448 | 0.030 |
Why?
|
| Isomerism | 1 | 1996 | 197 | 0.030 |
Why?
|
| Middle Aged | 19 | 2021 | 220359 | 0.030 |
Why?
|
| Extracellular Matrix | 2 | 2012 | 1726 | 0.030 |
Why?
|
| Depression | 1 | 2015 | 8045 | 0.030 |
Why?
|
| Astrocytes | 2 | 1995 | 1337 | 0.030 |
Why?
|
| Testis | 1 | 1999 | 794 | 0.030 |
Why?
|
| Receptors, Cholinergic | 3 | 1998 | 244 | 0.030 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2016 | 103 | 0.030 |
Why?
|
| Fibrosis | 2 | 2001 | 2042 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2003 | 5869 | 0.030 |
Why?
|
| Fetal Diseases | 2 | 1991 | 911 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 858 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 802 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1997 | 311 | 0.030 |
Why?
|
| Evolution, Molecular | 2 | 2003 | 1885 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1997 | 393 | 0.030 |
Why?
|
| Neuronal Apoptosis-Inhibitory Protein | 3 | 2000 | 11 | 0.030 |
Why?
|
| Reproduction | 1 | 2000 | 646 | 0.030 |
Why?
|
| Michigan | 1 | 2015 | 342 | 0.030 |
Why?
|
| Chickens | 2 | 1988 | 860 | 0.030 |
Why?
|
| Drosophila | 2 | 2018 | 1492 | 0.030 |
Why?
|
| Internet | 1 | 2007 | 3078 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1996 | 374 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 12628 | 0.030 |
Why?
|
| Translocation, Genetic | 4 | 1987 | 1388 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 18413 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 202 | 0.030 |
Why?
|
| Bacteriophage lambda | 2 | 1985 | 142 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1996 | 296 | 0.030 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2014 | 23 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 342 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2004 | 3380 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 1997 | 413 | 0.030 |
Why?
|
| Consanguinity | 2 | 2010 | 456 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 877 | 0.030 |
Why?
|
| Immunosorbent Techniques | 3 | 1988 | 176 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1997 | 1121 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2012 | 26179 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 388 | 0.030 |
Why?
|
| Time Factors | 4 | 2006 | 40139 | 0.030 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 105 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 412 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1993 | 107 | 0.030 |
Why?
|
| Phosphates | 1 | 1997 | 772 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 580 | 0.030 |
Why?
|
| Cricetinae | 2 | 1995 | 2427 | 0.030 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1973 | 77 | 0.030 |
Why?
|
| Cross Reactions | 2 | 1992 | 818 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1996 | 376 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 1999 | 801 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2000 | 1889 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 1994 | 168 | 0.030 |
Why?
|
| Neuromuscular Junction | 2 | 1992 | 406 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1994 | 430 | 0.030 |
Why?
|
| Rodentia | 1 | 1994 | 260 | 0.030 |
Why?
|
| Heart Failure | 1 | 1997 | 11848 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 2086 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 39262 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2006 | 3061 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1995 | 1763 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1485 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1992 | 67 | 0.030 |
Why?
|
| Spectrin | 1 | 1992 | 170 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2012 | 107 | 0.020 |
Why?
|
| Disease Progression | 3 | 2014 | 13505 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1995 | 814 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 719 | 0.020 |
Why?
|
| Movement | 1 | 2018 | 1474 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2019 | 1387 | 0.020 |
Why?
|
| Prejudice | 1 | 2015 | 563 | 0.020 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 959 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2627 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 1992 | 226 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 426 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 359 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 415 | 0.020 |
Why?
|
| Genomic Library | 1 | 1991 | 189 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1995 | 1234 | 0.020 |
Why?
|
| Mortality | 1 | 2002 | 2916 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 1996 | 753 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 726 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2006 | 3193 | 0.020 |
Why?
|
| Vacuoles | 1 | 2011 | 229 | 0.020 |
Why?
|
| Tubulin | 1 | 2014 | 692 | 0.020 |
Why?
|
| Age of Onset | 2 | 2010 | 3302 | 0.020 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1989 | 14 | 0.020 |
Why?
|
| Reading Frames | 1 | 1989 | 17 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 2014 | 424 | 0.020 |
Why?
|
| Cat Diseases | 1 | 1989 | 31 | 0.020 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1989 | 16 | 0.020 |
Why?
|
| Choroid Plexus | 1 | 1992 | 237 | 0.020 |
Why?
|
| Pyridostigmine Bromide | 1 | 2009 | 31 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1710 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Fluorescence | 1 | 1992 | 751 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 1993 | 613 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2011 | 154 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1837 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1997 | 1378 | 0.020 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 1989 | 50 | 0.020 |
Why?
|
| Glycerol Kinase | 1 | 1989 | 17 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1997 | 1380 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1989 | 1089 | 0.020 |
Why?
|
| Mothers | 1 | 2000 | 2186 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Purkinje Cells | 1 | 1990 | 226 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2014 | 1854 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1997 | 1572 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
| Immune Sera | 1 | 1989 | 613 | 0.020 |
Why?
|
| Twins | 1 | 1990 | 339 | 0.020 |
Why?
|
| Cell Movement | 2 | 2014 | 5206 | 0.020 |
Why?
|
| Myofibrils | 1 | 1989 | 141 | 0.020 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 1 | 1987 | 13 | 0.020 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2014 | 615 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1996 | 8158 | 0.020 |
Why?
|
| Gestational Age | 1 | 1997 | 3564 | 0.020 |
Why?
|
| Prospective Studies | 5 | 2019 | 54306 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2514 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1989 | 210 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 747 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1987 | 122 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1988 | 130 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 64981 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1989 | 303 | 0.020 |
Why?
|
| Boston | 2 | 2012 | 9278 | 0.020 |
Why?
|
| Tissue Donors | 1 | 1997 | 2314 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 13627 | 0.020 |
Why?
|
| Gene Frequency | 3 | 2001 | 3613 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2001 | 693 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1399 | 0.020 |
Why?
|
| Midazolam | 1 | 2009 | 267 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 238 | 0.020 |
Why?
|
| DNA Repair | 1 | 1997 | 2038 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 2197 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 534 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6915 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1994 | 1334 | 0.020 |
Why?
|
| Syndrome | 3 | 1989 | 3280 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1990 | 623 | 0.020 |
Why?
|
| Income | 1 | 2015 | 1875 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1986 | 31 | 0.020 |
Why?
|
| Adrenal Insufficiency | 1 | 1989 | 192 | 0.020 |
Why?
|
| DNA, Circular | 1 | 1987 | 97 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1987 | 228 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1987 | 182 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1998 | 3663 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 513 | 0.020 |
Why?
|
| Nervous System | 1 | 1990 | 543 | 0.020 |
Why?
|
| Microinjections | 1 | 2007 | 321 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 1986 | 95 | 0.020 |
Why?
|
| Quail | 1 | 2006 | 40 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1988 | 1060 | 0.020 |
Why?
|
| Anemia | 1 | 2015 | 1511 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 1992 | 1019 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3618 | 0.020 |
Why?
|
| Community Mental Health Centers | 1 | 2006 | 93 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 4742 | 0.020 |
Why?
|
| Placenta | 1 | 1995 | 1702 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 2275 | 0.020 |
Why?
|
| Clone Cells | 1 | 1989 | 1663 | 0.020 |
Why?
|
| Somites | 1 | 2006 | 60 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 1342 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6216 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2003 | 2935 | 0.020 |
Why?
|
| Meiosis | 1 | 1986 | 328 | 0.010 |
Why?
|
| Algorithms | 3 | 2019 | 13982 | 0.010 |
Why?
|
| Chimera | 1 | 2006 | 453 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1973 | 892 | 0.010 |
Why?
|
| Macrophages | 1 | 2019 | 5745 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1992 | 1415 | 0.010 |
Why?
|
| Phylogeny | 1 | 2012 | 2775 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1986 | 173 | 0.010 |
Why?
|
| Homeostasis | 1 | 1995 | 3306 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 2009 | 12968 | 0.010 |
Why?
|
| Metaphase | 1 | 1984 | 144 | 0.010 |
Why?
|
| Postmortem Changes | 1 | 2004 | 119 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2006 | 981 | 0.010 |
Why?
|
| Haplorhini | 1 | 2004 | 529 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 2003 | 45 | 0.010 |
Why?
|
| RNA Probes | 1 | 2003 | 111 | 0.010 |
Why?
|
| Statistical Distributions | 1 | 2003 | 63 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1987 | 631 | 0.010 |
Why?
|
| Retroviridae | 1 | 2006 | 850 | 0.010 |
Why?
|
| Epitopes | 1 | 1989 | 2503 | 0.010 |
Why?
|
| Ion Channels | 1 | 1987 | 1043 | 0.010 |
Why?
|
| Respiration | 1 | 2009 | 1654 | 0.010 |
Why?
|
| Neuroglia | 1 | 1988 | 944 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1529 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 1178 | 0.010 |
Why?
|
| Melanoma | 1 | 2000 | 5697 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2688 | 0.010 |
Why?
|
| Calibration | 1 | 2003 | 816 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4446 | 0.010 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2002 | 226 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Legionella pneumophila | 1 | 2000 | 49 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 10181 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11890 | 0.010 |
Why?
|
| Turkey | 1 | 2000 | 248 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2001 | 1142 | 0.010 |
Why?
|
| Splenectomy | 1 | 2000 | 391 | 0.010 |
Why?
|
| Troponin T | 1 | 2004 | 774 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1993 | 3976 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10826 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 255 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 732 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2000 | 330 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2476 | 0.010 |
Why?
|
| Chromosome Banding | 2 | 1990 | 260 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1437 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2001 | 987 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1985 | 2194 | 0.010 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1997 | 62 | 0.010 |
Why?
|
| Logistic Models | 1 | 2012 | 13312 | 0.010 |
Why?
|
| Environment | 1 | 2003 | 1118 | 0.010 |
Why?
|
| Pregnancy | 3 | 1995 | 29746 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16932 | 0.010 |
Why?
|
| Transcription Factor TFIIH | 1 | 1997 | 30 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10553 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2829 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1997 | 12102 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 2924 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 9591 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2235 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 1369 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 224 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 865 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 6015 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6498 | 0.010 |
Why?
|
| Genomics | 1 | 2011 | 5795 | 0.010 |
Why?
|
| United States | 3 | 2016 | 72448 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4611 | 0.010 |
Why?
|
| Hypotension | 1 | 2001 | 883 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15686 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2006 | 2782 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1996 | 388 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4775 | 0.010 |
Why?
|
| Italy | 1 | 1996 | 841 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 25941 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1997 | 545 | 0.010 |
Why?
|
| New Hampshire | 1 | 1994 | 173 | 0.010 |
Why?
|
| Mustard Compounds | 1 | 1973 | 4 | 0.010 |
Why?
|
| Quinacrine | 1 | 1973 | 24 | 0.010 |
Why?
|
| Dermatoglyphics | 1 | 1973 | 20 | 0.010 |
Why?
|
| Ontario | 1 | 1994 | 404 | 0.010 |
Why?
|
| Dyspnea | 1 | 2001 | 1353 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4899 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 1074 | 0.010 |
Why?
|
| Tritium | 1 | 1973 | 707 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5877 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1997 | 1218 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1992 | 101 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 6048 | 0.010 |
Why?
|
| Autoradiography | 1 | 1973 | 730 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 181 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2869 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1978 | 1521 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2002 | 2629 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 6379 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 1995 | 1996 | 0.010 |
Why?
|
| Deoxyribonucleases, Type III Site-Specific | 1 | 1989 | 1 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2873 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 8552 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1989 | 700 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6130 | 0.000 |
Why?
|
| Cats | 1 | 1989 | 976 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1997 | 2007 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2006 | 12914 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2001 | 6415 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1997 | 5434 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2000 | 8556 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3390 | 0.000 |
Why?
|
| Phosphoglucomutase | 1 | 1985 | 6 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14661 | 0.000 |
Why?
|
| Carrier State | 1 | 1989 | 525 | 0.000 |
Why?
|
| Survival Rate | 1 | 2000 | 12810 | 0.000 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1985 | 65 | 0.000 |
Why?
|
| Methylation | 1 | 1988 | 1081 | 0.000 |
Why?
|
| Codon | 1 | 1986 | 602 | 0.000 |
Why?
|
| Health Care Costs | 1 | 1997 | 3258 | 0.000 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1991 | 1745 | 0.000 |
Why?
|
| Cricetulus | 1 | 1985 | 815 | 0.000 |
Why?
|
| Fragile X Syndrome | 1 | 1984 | 116 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11152 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15286 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 8950 | 0.000 |
Why?
|
| Genetic Techniques | 1 | 1978 | 428 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2003 | 80345 | 0.000 |
Why?
|
| Amino Acids | 1 | 1978 | 1714 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1978 | 2362 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 3610 | 0.000 |
Why?
|